AI life sciences unicorn raises $150M for platform ops; 10 rare disease companies form new lobbying group
Bain Capital just endorsed the notion that AI and big data are coming of age in the life sciences industry.
Their Tech Opportunities team is investing $150 million in the 11-year-old data management and AI platform operation at Axtria, which plans to use the money to build up its platform for cloud software and artificial intelligence in life sciences. Those plans could include M&A for the company, which Bloomberg reports used a valuation of $1 billion in raising this cash.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.